Fluoroscopy-Guided Microwave Ablation after Transarterial Chemoembolization with Drug-coated Bead LUMI Radiopaque Beads

Fluoroscopy-Guided Microwave Ablation after Transarterial Chemoembolization with Drug-coated Bead LUMI Radiopaque Beads

Bibliographic Details
Main Authors:	Aeed Saad AlAklabi, Ghazy Abdulelah Bukhary, Refaat Salman
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2019-01-01
Series:	The Arab Journal of Interventional Radiology
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.4103/AJIR.AJIR_45_18

Similar Items

Transarterial Chemoembolization with LC Bead LUMI followed by Stereotactic Body Radiation Therapy in Treatment of Hepatocellular Carcinoma
by: Evrosina I. Isaac, BS, et al.
Published: (2022-01-01)

Efficacy and Safety of Transarterial Chemoembolization with DC Beads LUMI in the Treatment of HCC: Experience from a Tertiary Centre
by: Pierpaolo Biondetti MD, PhD, et al.
Published: (2023-08-01)

Synthesis, characterization, and imaging of radiopaque bismuth beads for image-guided transarterial embolization
by: Ayele H. Negussie, et al.
Published: (2021-01-01)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
by: Baur J, et al.
Published: (2016-06-01)

Preliminary outcomes of raltitrexed eluting bead-transarterial chemoembolization using Callispheres® beads for gastrointestinal adenocarcinoma liver metastasis
by: Yonghua Bi, et al.
Published: (2022-07-01)

Bronchial Artery Chemoembolization With Radiopaque Doxorubicin Eluding Beads in Patients With Malignant Hemoptysis from Metastatic Lung Cancer
by: Nariman Nezami MD, et al.
Published: (2022-10-01)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
by: Yanqiao Ren, et al.
Published: (2022-03-01)

Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma
by: Rusi Zhang, et al.
Published: (2018-07-01)

Drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma: does size really matter?
by: Sieh-Yang Lee, et al.
Published: (2020-05-01)

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
by: Hyun Young Woo, et al.
Published: (2015-12-01)

Delayed Intratumoral Hemorrhage after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Kazue Shiozawa, et al.
Published: (2014-11-01)

Role of drug-eluting beads versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud Abu Elfadl, et al.
Published: (2019-01-01)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
by: Zhang W, et al.
Published: (2021-07-01)

Effectiveness of drug-eluting bead transarterial chemoembolization versus conventional transarterial chemoembolization for small hepatocellular carcinoma in Child-Pugh class A patients
by: In Joon Lee, et al.
Published: (2019-08-01)

Efficacy of Transarterial Chemoembolization with Drug-Eluting Beads in Hepatocellular Carcinoma: A Single-Center Experience
by: Erbil Arık, et al.
Published: (2022-08-01)

Transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma: response analysis with mRECIST
by: Claudia Domaratius, et al.
Published: (2021-01-01)

Cost-effectiveness analysis of drug-eluting beads and conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Guoliang Shao, et al.
Published: (2022-10-01)

Determination of Risk Factors for Pain After Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma
by: Wang TC, et al.
Published: (2020-03-01)

Doxorubicin-loaded drug-eluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinoma
by: Mohammad Arabi, et al.
Published: (2015-01-01)

Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus
by: Junwei Chen, et al.
Published: (2023-07-01)

Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study
by: Ouyang T, et al.
Published: (2021-11-01)

Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study [Retraction]
by: Ouyang T, et al.
Published: (2022-01-01)

Dual-balloon infusion microcatheter for selective drug-eluting bead transarterial chemoembolization: initial feasibility study
by: Wayne L. Monsky, et al.
Published: (2017-11-01)

Transarterial chemoembolization of unresectable renal cell carcinoma with doxorubicin-loaded CalliSpheres drug-eluting beads
by: Yonghua Bi, et al.
Published: (2022-05-01)

Clinical outcomes of doxorubicin-eluting CalliSpheres® beads-transarterial chemoembolization for unresectable or recurrent esophageal carcinoma
by: Yonghua Bi, et al.
Published: (2021-05-01)

Transarterial Chemoembolization and Microwave Ablation for Early Hepatocellular Carcinoma in a Nigerian
by: Ninalowo Hammed, et al.
Published: (2022-01-01)

Conventional Transarterial Chemoembolization Versus Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
by: Khalid I. Bzeizi, et al.
Published: (2021-12-01)

Predicting Therapeutic Efficacy of Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound
by: Kazue Shiozawa, et al.
Published: (2021-02-01)

The safety and efficacy of oxaliplatin-loaded drug-eluting beads transarterial chemoembolization for the treatment of unresectable or advanced lung cancer
by: Yonghua Bi, et al.
Published: (2022-11-01)

Tumor Response and Nomogram-Based Prognostic Stratification for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization
by: Ji K, et al.
Published: (2022-06-01)

Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads.
by: Jin Woo Choi, et al.
Published: (2014-01-01)

Liver MRI and clinical findings to predict response after drug eluting bead transarterial chemoembolization in hepatocellular carcinoma
by: Jeong Yeop Lee, et al.
Published: (2021-12-01)

Conventional versus drug-eluting bead transarterial chemoembolization: A better option for treatment of unresectable hepatocellular carcinoma
by: Murtuza Razi, et al.
Published: (2021-02-01)

Transarterial chemoembolization using drug-eluting bead compared with radiofrequency ablation for treatment of single small hepatocellular carcinoma: a pilot non-randomized trial
by: Tae Hoon Kim, et al.
Published: (2021-09-01)

A Comparison of Adverse Events Among Radiofrequency Ablation, Conventional Transarterial Chemoembolization (TACE) and Drug-Eluting Bead TACE in Treating Hepatocellular Carcinoma Patients
by: Cao G, et al.
Published: (2021-07-01)

The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma
by: Hao Li, et al.
Published: (2023-12-01)

Efficacy of transarterial chemoembolization with drug-eluting beads combined with systemic chemotherapy and targeted therapy in colorectal cancer liver metastasis
by: Yen-Cheng Chen, et al.
Published: (2023-12-01)

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
by: Su Jong Yu, et al.
Published: (2023-03-01)

Experimental study of camptothecin combined with drug-eluting bead transarterial chemoembolization in the rabbit VX2 liver tumor model
by: Fanguang Meng, et al.
Published: (2022-10-01)

The efficacy of drug-eluting bead or conventional transarterial chemoembolization plus apatinib for hepatocellular carcinoma with portal vein tumor thrombus
by: Weihua Zhang, et al.
Published: (2022-04-01)